NO953892D0 - Imidazolokinoksalinon-derivater som EAA-antagonister - Google Patents

Imidazolokinoksalinon-derivater som EAA-antagonister

Info

Publication number
NO953892D0
NO953892D0 NO953892A NO953892A NO953892D0 NO 953892 D0 NO953892 D0 NO 953892D0 NO 953892 A NO953892 A NO 953892A NO 953892 A NO953892 A NO 953892A NO 953892 D0 NO953892 D0 NO 953892D0
Authority
NO
Norway
Prior art keywords
imidazoloquinoxalinone
derivatives
preparation
eaa antagonists
eaa
Prior art date
Application number
NO953892A
Other languages
English (en)
Other versions
NO953892L (no
Inventor
Hans-Joerg Treiber
Berthold Behl
Hans Peter Hofmann
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4329970A external-priority patent/DE4329970A1/de
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO953892L publication Critical patent/NO953892L/no
Publication of NO953892D0 publication Critical patent/NO953892D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO953892A 1993-03-31 1995-09-29 Imidazolokinoksalinon-derivater som EAA-antagonister NO953892D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4310521 1993-03-31
DE4329970A DE4329970A1 (de) 1993-03-31 1993-09-04 Neue Imidazolo-chinoxalinone, ihre Hestellung und Verwendung
PCT/EP1994/000871 WO1994022865A1 (de) 1993-03-31 1994-03-19 Imidazolochinoxalinonderivate als eaa antagonisten

Publications (2)

Publication Number Publication Date
NO953892L NO953892L (no) 1995-09-29
NO953892D0 true NO953892D0 (no) 1995-09-29

Family

ID=25924528

Family Applications (1)

Application Number Title Priority Date Filing Date
NO953892A NO953892D0 (no) 1993-03-31 1995-09-29 Imidazolokinoksalinon-derivater som EAA-antagonister

Country Status (17)

Country Link
EP (1) EP0691970B1 (no)
JP (1) JPH08508271A (no)
CN (1) CN1041928C (no)
AT (1) ATE173263T1 (no)
AU (1) AU6428294A (no)
BR (1) BR9406034A (no)
CA (1) CA2158167A1 (no)
CZ (1) CZ246495A3 (no)
FI (1) FI954614A0 (no)
HR (1) HRP940210A2 (no)
HU (1) HUT73970A (no)
IL (1) IL109076A (no)
NO (1) NO953892D0 (no)
NZ (1) NZ263552A (no)
PL (1) PL310950A1 (no)
SI (1) SI9420023A (no)
WO (1) WO1994022865A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT76323A (en) * 1994-02-11 1997-08-28 Novo Nordisk As Imidazo[1,2-a]quinoxalinone derivatives, process for their preparation and pharmaceutical compositions containing them
FR2722789B1 (fr) * 1994-07-20 1996-08-23 Rhone Poulenc Rorer Sa Derives d'acide imidazo (1,2-a)indeno(1,2-e) pyrazine-2-carboxylique, leur preparation et les medicaments les contenant
IT1276167B1 (it) * 1995-11-24 1997-10-27 Foscama Biomed Chim Farma Imidazo(1,2-alfa)chinossalin-4-ammine attivi come antagonisti adenosinici,procedimento per la loro preparazione e loro composizioni
FR2743363A1 (fr) * 1996-01-10 1997-07-11 Rhone Poulenc Rorer Sa 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-a-ones substituees en position 2, leur preparation et les medicaments les contenant
US6271418B1 (en) * 2000-02-22 2001-08-07 Nippon Kayaku Co., Ltd. Process for preparing (hetero) aromatic substituted benzene derivatives
GB0017518D0 (en) 2000-07-17 2000-08-30 Merck Sharp & Dohme Therapeutic agents
GB0018473D0 (en) * 2000-07-27 2000-09-13 Merck Sharp & Dohme Therapeutic agents
CN100386326C (zh) * 2003-10-22 2008-05-07 中国人民解放军军事医学科学院毒物药物研究所 1-羟甲基咪唑并[1，2-a]喹喔啉化合物及其应用
EP2103613B1 (en) * 2006-12-13 2016-02-17 ASKA Pharmaceutical Co., Ltd. Quinoxaline derivative
FR2921927B1 (fr) * 2007-10-03 2012-10-12 Univ De Montpellier 1 Imidazo°1,2-a!quinoxalines et derives pour le traitement des cancers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2043064B (en) * 1979-02-09 1983-04-13 Roussel Lab Ltd Oximidazoquinoxaline derivatives
US5153196A (en) * 1991-06-05 1992-10-06 Eli Lilly And Company Excitatory amino acid receptor antagonists and methods for the use thereof
US5182386A (en) * 1991-08-27 1993-01-26 Neurogen Corporation Certain imidazoquinoxalinones; a new class of gaba brain receptor ligands

Also Published As

Publication number Publication date
FI954614A (fi) 1995-09-28
HUT73970A (en) 1996-10-28
IL109076A (en) 1997-06-10
NO953892L (no) 1995-09-29
BR9406034A (pt) 1996-01-02
CN1120336A (zh) 1996-04-10
ATE173263T1 (de) 1998-11-15
CZ246495A3 (en) 1996-03-13
WO1994022865A1 (de) 1994-10-13
SI9420023A (en) 1996-04-30
EP0691970A1 (de) 1996-01-17
FI954614A0 (fi) 1995-09-28
HRP940210A2 (en) 1996-12-31
CN1041928C (zh) 1999-02-03
JPH08508271A (ja) 1996-09-03
CA2158167A1 (en) 1994-10-13
AU6428294A (en) 1994-10-24
IL109076A0 (en) 1994-06-24
PL310950A1 (en) 1996-01-08
HU9502848D0 (en) 1995-11-28
EP0691970B1 (de) 1998-11-11
NZ263552A (en) 1997-06-24

Similar Documents

Publication Publication Date Title
ATE203019T1 (de) Neue (r)-5-carbamoyl-8-fluor-3-n,n- disubstituierte-amino-3,4-dihydro-2h-1- benzopyrane
FI924847A0 (fi) 2-aminometyl-kromaner
NO20050807L (no) Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser
DK0668863T3 (da) Quinuclidinderivat som substans P-antagonist
GR3019450T3 (en) Azaheterocyclylmethyl-chromans as agents for the treatment of diseases of the central nervous system
MY110110A (en) Pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and cns disorders
DK0751939T5 (da) Naphthylamider som centralnervesystemmidler
DK0713701T3 (da) 2-Brommelatonin til behandling af søvnforstyrrelser
TW352384B (en) Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals
ATE77747T1 (de) 3-(aminopropyl)methyl-phosphinsaeure als therapeutisches mittel.
SE9702564D0 (sv) New compounds
DK0520200T3 (da) Imadazol-forbindelser, deres fremstilling og anvendelse
NO953892D0 (no) Imidazolokinoksalinon-derivater som EAA-antagonister
ATE381533T1 (de) Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung
BR9803385A (pt) AtropisÈmeros de 2,3-dissubstituìdo-(5,6)-heteroaril condensado-pirimidin-4-onas.
HUP0100611A2 (hu) Triazin vegyületek, és ilyeneket tartalmazó gyógyszerkészítmények a központi idegrendszer elváltozásainak kezelésére
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
NO982863L (no) Nye forbindelser med analgetisk effekt
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
NO984651L (no) Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet
TR199901385T2 (xx) Piperidin t�revleri.
NO20020914D0 (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
PT889044E (pt) Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central
DK0950053T3 (da) Hidtil ukendte benzoylalkyl.1,2,3,6-tetrahydropyridinderivater
TR200000916T2 (tr) İkameli piperidin türevleri.